Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
about
Pharmacogenomics of human P450 oxidoreductaseInfluence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6Concomitant mutations in the P450 oxidoreductase and androgen receptor genes presenting with 46,XY disordered sex development and androgenization at adrenarche.Suppression of cytochrome p450 reductase enhances long-term hematopoietic stem cell repopulation efficiency in mice.Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patientsGenetic variations in NADPH-CYP450 oxidoreductase in a Czech Slavic cohort.NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology.Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.Pharmacogenetic-based clinical scores: a useful, simple tool to predict tamoxifen-based CYP2D6 phenotype?Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers.POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia.Direct observation of multiple conformational states in Cytochrome P450 oxidoreductase and their modulation by membrane environment and ionic strength
P2860
Q26998463-369E7F7C-5F40-4D1F-A424-E8D4A99E7A6CQ28484196-C54C19AF-8ED9-4004-B02D-381429A47675Q34766752-2C0A19CE-40C0-49A8-87C3-C5243B9F4BE9Q34904803-33AE801F-4099-40D3-B1BD-36FBDD4BEB16Q35662487-0E261605-8227-45D6-9FB3-4D9017FB07BEQ36326565-79D31B04-6BAA-45C4-896E-5CFB54B84A0AQ36497649-719EF6DB-8B5B-4AE3-B2E1-3B65248B584FQ37698004-99528812-FDE3-4F04-B54E-055223219896Q43188221-A1D66C05-28F9-4562-B016-53CDB4AE79B5Q44556926-24B91EC4-B421-4523-B6B6-32E20C538CEDQ53665083-CB82CC18-3106-4A66-845E-1BEC61549F93Q55112848-B9113ACF-4BA7-4A6D-9E38-BEF9AEF1C4D5
P2860
Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical, structural and funct ...... man NADPH P450 oxidoreductase.
@en
type
label
Clinical, structural and funct ...... man NADPH P450 oxidoreductase.
@en
prefLabel
Clinical, structural and funct ...... man NADPH P450 oxidoreductase.
@en
P2860
P1476
Clinical, structural and funct ...... man NADPH P450 oxidoreductase.
@en
P2093
Catherine Nicolo
Christa E Flück
P2860
P304
P356
10.1111/J.1472-8206.2007.00520.X
P577
2007-08-01T00:00:00Z